Factors associated with poor prognosis of hip arthritis in juvenile idiopathic arthritis: Data from the JIR cohort.
MRI
NSAIDs
anti-TNF
arthritis
hip
juvenile idiopathic arthritis
methotrexate
outcomes
ultrasound
x-rays
Journal
Musculoskeletal care
ISSN: 1557-0681
Titre abrégé: Musculoskeletal Care
Pays: England
ID NLM: 101181344
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
revised:
22
02
2023
received:
18
01
2023
accepted:
23
02
2023
medline:
11
9
2023
pubmed:
11
3
2023
entrez:
10
3
2023
Statut:
ppublish
Résumé
Hip involvement remains a predictor of severe juvenile idiopathic arthritis (JIA) course and carries a high risk of disability. This study aims to determine the factors of poor prognosis of hip involvement in patients with JIA and to assess the treatment response. This is a multicenter observational cohort study. Patients were selected from the JIR Cohort database. Hip involvement was defined as clinically suspected and confirmed by an imaging tool. Follow-up data were collected during 5 years. Among the 2223 patients with JIA, 341(15%) patients had hip arthritis. Male gender, enthesitis-related arthritis, and North African origin were factors associated with hip arthritis. Hip inflammation was associated with disease activity parameters during the first year, particularly Physician Global Assessment, joint count, and inflammatory marks. Structural hip progression was associated with early onset of the disease, a longer time to diagnosis, geographic origin, and JIA subtypes. Anti-TNF therapy was found to be the only treatment able to effectively reduce structural damage progression. The early onset diagnostic delay, origin, and systemic subtype of JIA predict a poor prognosis of hip arthritis in children with JIA. The use of anti-TNF was associated with a better structural prognosis.
Substances chimiques
Tumor Necrosis Factor Inhibitors
0
Types de publication
Observational Study
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
806-814Informations de copyright
© 2023 John Wiley & Sons Ltd.
Références
Agrawal, Y., Kerry, R. M., Stockley, I., & Hamer, A. J. (2021). Review of total hip arthroplasty in patients younger than 30 years: Mid-to long-term results. Hip International, 31(4), 533-541. https://doi.org/10.1177/1120700020901685
Blane, C. E., Ragsdale, C. G., & Hensinger, R. N. (1987). Late effects of JRA on the hip. Journal of Pediatric Orthopaedics, 7(6), 677-680. https://doi.org/10.1097/01241398-198707060-00009
Hampton, S. N., Nakonezny, P. A., Richard, H. M., & Wells, J. E. (2019). Pain catastrophizing, anxiety, and depression in hip pathology. The Bone & Joint Journal, 101-B(7), 800-807. https://doi.org/10.1302/0301-620x.101b7.bjj-2018-1309.r1
Harel, L., Wagner-Weiner, L., Poznanski, A. K., Spencer, C. H., Ekwo, E., & Magilavy, D. B. (1993). Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis. Arthritis & Rheumatology, 36(10), 1370-1374. https://doi.org/10.1002/art.1780361007
Harris, C. M., & Baum, J. (1988). Involvement of the hip in juvenile rheumatoid arthritis. A longitudinal study. The Journal of Bone and Joint Surgery, 70(6), 821-833. https://doi.org/10.2106/00004623-198870060-00004
Heidt, C., Grueberger, N., Grisch, D., Righini-Grunder, F., Rueger, M., & Ramseier, L. (2021). The assessment of steroid injections as a potential risk factor for osteochondral lesions in children with juvenile idiopathic arthritis. Cartilage, 13(1_suppl), 894S-899S. https://doi.org/10.1177/1947603520961173
Helenius, I. J., Viehweger, E., & Castelein, R. M. (2020). Cerebral palsy with dislocated hip and scoliosis: What to deal with first? Journal of Children's Orthopaedics, 14(1), 24-29. https://doi.org/10.1302/1863-2548.14.190099
Inaba, Y., Ozawa, R., Aoki, C., Imagawa, T., Mori, M., Hara, R., Miyamae, T., Saito, T., & Yokota, S. (2013). Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis. Modern Rheumatology, 23(4), 667-673. https://doi.org/10.1007/s10165-012-0711-0
López-Medina, C., Molto, A., Sieper, J., Duruöz, T., Kiltz, U., Elzorkany, B., Hajjaj-Hassouni, N., Burgos-Vargas, R., Maldonado-Cocco, J., Ziade, N., Gavali, M., Navarro-Compan, V., Luo, S. F., Monti, S., Tae-Jong, K., Kishimoto, M., Pimentel-Santos, F. M., Gu, J., Schiotis, R., … Dougados, M. (2021). Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: Results of the worldwide, cross-sectional ASAS-PerSpA study. RMD Open, 7(1), e001450. https://doi.org/10.1136/rmdopen-2020-001450
Mahmoud, I., Maatallah, K., Ben Nessib, D., Belghali, S., Ben Abdelghani, K., Metoui, L., Saidane, O., Hamdi, W., Zouari, B., Ben Salem, K., Tekaya, R., & Abdelmoula, L. (2020). Long term inhibition of hip joint damage under tumor necrosis factor-alpha inhibitors in spondyloarthritis. International Immunopharmacology, 88, 106927. https://doi.org/10.1016/j.intimp.2020.106927
Malattia, C., Rinaldi, M., & Martini, A. (2018). The role of imaging in juvenile idiopathic arthritis. Expert Review of Clinical Immunology, 14(8), 681-694. https://doi.org/10.1080/1744666x.2018.1496019
Martini, A., Ravelli, A., Avcin, T., Beresford, M. W., Burgos-Vargas, R., Cuttica, R., Ilowite, N. T., Khubchandani, R., Laxer, R. M., Lovell, D. J., Petty, R. E., Wallace, C. A., Wulffraat, N. M., Pistorio, A., & Ruperto, N. (2019). Toward new classification criteria for juvenile idiopathic arthritis: First steps, pediatric rheumatology international trials organization international consensus. The Journal of Rheumatology, 46(2), 190-197. https://doi.org/10.3899/jrheum.180168
Modesto, C., Woo, P., García-Consuegra, J., Merino, R., García-Granero, M., Arnal, C., & Prieur, A. M. (2001). Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis. Clinical and Experimental Rheumatology, 19(2), 211-217.
Naveen, R., Mohindra, N., Jain, N., Majumder, S., & Aggarwal, A. (2021). Hip involvement in children with enthesitis related arthritis (ERA) is associated with poor outcomes in adulthood. Clinical Rheumatology, 40(11), 4619-4627. https://doi.org/10.1007/s10067-021-05807-3
Neidel, J., Boehnke, M., & Küster, R. M. (2002). The efficacy and safety of intraarticular corticosteroid therapy for coxitis in juvenile rheumatoid arthritis. Arthritis & Rheumatology, 46(6), 1620-1628. https://doi.org/10.1002/art.10313
Oliveira-Ramos, F., Eusébio, M., Martins, F., Mourão, A. F., Furtado, C., Campanilho-Marques, R., Cordeiro, I., Ferreira, J., Cerqueira, M., Figueira, R., Brito, I., Canhao, H., Santos, M. J., Melo-Gomes, J. A., & Fonseca, J. E. (2016). Juvenile idiopathic arthritis in adulthood: Fulfilment of classification criteria for adult rheumatic diseases, long-term outcomes and predictors of inactive disease, functional status and damage. RMD Open, 2(2), e000304. https://doi.org/10.1136/rmdopen-2016-000304
Patriquin, H. B., Camerlain, M., & Trias, A. (1984). Late sequelae of juvenile rheumatoid arthritis of the hip: A follow-up study into adulthood. Pediatric Radiology, 14(3), 151-157. https://doi.org/10.1007/bf01002300
Remy, A., & Combe, B. (2014). Repair of radiographic hip joint in juvenile rheumatoid arthritis patients treated with etanercept plus methotrexate. Joint Bone Spine, 81(5), 447-449. https://doi.org/10.1016/j.jbspin.2014.03.006
Rostom, S., Amine, B., Bensabbah, R., Abouqal, R., & Hajjaj-Hassouni, N. (2008). Hip involvement in juvenile idiopathic arthritis. Clinical Rheumatology, 27(6), 791-794. https://doi.org/10.1007/s10067-008-0853-9
Russo, R. A. G., & Katsicas, M. M. (2013). Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome. The Journal of Rheumatology, 40(3), 329-334. https://doi.org/10.3899/jrheum.120386
Rypdal, V., Arnstad, E. D., Aalto, K., Berntson, L., Ekelund, M., Fasth, A., Glerup, M., Herlin, T., Nielsen, S., Peltoniemi, S., Zak, M., Rygg, M., Rypdal, M., & Nordal, E. (2018). Predicting unfavorable long-term outcome in juvenile idiopathic arthritis: Results from the Nordic cohort study. Arthritis Research and Therapy, 20(1), 91. https://doi.org/10.1186/s13075-018-1571-6
Scott, C., Meiorin, S., Filocamo, G., Lanni, S., Valle, M., Martinoli, C., Martini, A., & Rovelli, A. (2010). A reappraisal of intra-articular corticosteroid therapy in juvenile idiopathic arthritis. Clinical & Experimental Rheumatology, 28(5), 774-781.
Shelmerdine, S. C., Di Paolo, P. L., Tanturri de Horatio, L., Malattia, C., Magni-Manzoni, S., & Rosendahl, K. (2018). Imaging of the hip in juvenile idiopathic arthritis. Pediatric Radiology, 48(6), 811-817. https://doi.org/10.1007/s00247-017-4022-7
Singh, J. A., & Cleveland, J. D. (2021). Juvenile idiopathic arthritis is associated with higher healthcare utilization after total knee or hip replacement. Scandinavian Journal of Rheumatology, 50(1), 34-39. https://doi.org/10.1080/03009742.2020.1760930
Spencer, C. H., & Bernstein, B. H. (2002). Hip disease in juvenile rheumatoid arthritis. Current Opinion in Rheumatology, 14(5), 536-541. https://doi.org/10.1097/00002281-200209000-00010
Sulpice, M., Deslandre, C. J., & Quartier, P. (2009). Efficacy and safety of TNFalpha antagonist therapy in patients with juvenile spondyloarthropathies. Joint Bone Spine, 76(1), 24-27. https://doi.org/10.1016/j.jbspin.2008.03.008
Swarup, I., Leeyu, Y., Christoph, E. I., Mandl, L. A., Goodman, S. M., & Figgie, M. P. (2015). Implant survival and patient-reported outcomes after total hip arthroplasty in young patients with juvenile idiopathic arthritis. The Journal of Arthroplasty, 30(3), 398-402. https://doi.org/10.1016/j.arth.2014.09.018
Weiß, A., Minden, K., Listing, J., Foeldvari, I., Sieper, J., & Rudwaleit, M. (2017). Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPIC. RMD Open, 3(1), e000366. https://doi.org/10.1136/rmdopen-2016-000366
Williams, R. A., & Ansell, B. M. (1985). Radiological findings in seropositive juvenile chronic arthritis (juvenile rheumatoid arthritis) with particular reference to progression. Annals of Rheumatic Diseases, 44(10), 685-693. https://doi.org/10.1136/ard.44.10.685